Beken Bio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $750K

  • Investors
  • 8

Beken Bio General Information

Description

Developer of diagnostic technology designed to provide early cancer detection. The company specializes in identifying pre-symptomatic cancer biomarkers through a proprietary three-dimensional cell growth platform and AI-driven protein analysis to detect cancer at an early stage, enabling clinicians to detect cancer early and improve patient survival outcomes.

Contact Information

Website
www.beken.bio
Formerly Known As
CellSpring
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9276 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 9276 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States

Beken Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beken Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 31-Dec-2025 $750K Completed Generating Revenue
11. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Grant 24-Sep-2024 Completed Generating Revenue
8. Grant 15-Aug-2024 Completed Generating Revenue
7. Accelerator/Incubator 15-May-2019 Completed Generating Revenue
6. Accelerator/Incubator 19-Jan-2016 Completed Startup
5. Grant 17-Nov-2015 Completed Startup
4. Grant 11-Nov-2015 $153K $11.2K Completed Startup
3. Grant 12-Nov-2014 $20K $11.2K Completed Startup
To view Beken Bio’s complete valuation and funding history, request access »

Beken Bio Patents

Beken Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201706993-D0 Method for obtaning extracellular vesicles Inactive 03-May-2017

Beken Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beken Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
1834 Ventures Venture Capital Minority
Boot64 Ventures Venture Capital Minority
Community Development Venture Capital Alliance Not-For-Profit Venture Capital Minority
Tulane Ventures Venture Capital Minority
Curebound Not-For-Profit Venture Capital
You’re viewing 5 of 8 investors. Get the full list »

Beken Bio FAQs

  • When was Beken Bio founded?

    Beken Bio was founded in 2014.

  • Where is Beken Bio headquartered?

    Beken Bio is headquartered in San Diego, CA.

  • What is the size of Beken Bio?

    Beken Bio has 5 total employees.

  • What industry is Beken Bio in?

    Beken Bio’s primary industry is Diagnostic Equipment.

  • Is Beken Bio a private or public company?

    Beken Bio is a Private company.

  • What is Beken Bio’s current revenue?

    The current revenue for Beken Bio is .

  • How much funding has Beken Bio raised over time?

    Beken Bio has raised $986K.

  • Who are Beken Bio’s investors?

    1834 Ventures, Boot64 Ventures, Community Development Venture Capital Alliance, Tulane Ventures, and Curebound are 5 of 8 investors who have invested in Beken Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process